Another research was done in 2020 to study the effect of rs1076560 (dopamine receptor D2 or DRD2) and rs4680 (COMT Val158Met) on tardive dyskinesia and cognition in schizophrenia patients. The gene discussed is DRD2; the disease is schizophrenia.